{"id":3093,"date":"2020-03-04T16:34:00","date_gmt":"2020-03-04T16:34:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=3093"},"modified":"2025-01-14T22:14:23","modified_gmt":"2025-01-14T22:14:23","slug":"modelling-nafld-disease-burden-in-four-asian-regions-2019-2030","status":"publish","type":"post","link":"https:\/\/cdafound.org\/es\/modelling-nafld-disease-burden-in-four-asian-regions-2019-2030\/","title":{"rendered":"Modelado de la carga de enfermedad de NAFLD en cuatro regiones asi\u00e1ticas, 2019-2030"},"content":{"rendered":"

Resumen<\/h2>\n\n\n\n

Fondo<\/h3>\n\n\n\n

La enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) representan una proporci\u00f3n cada vez mayor de enfermedad hep\u00e1tica en la regi\u00f3n de Asia y el Pac\u00edfico. Muchas \u00e1reas de la regi\u00f3n est\u00e1n experimentando epidemias de s\u00edndrome metab\u00f3lico entre poblaciones que envejecen r\u00e1pidamente.<\/p>\n\n\n\n

Objetivos<\/h3>\n\n\n\n

Estimar mediante modelos el crecimiento de las poblaciones de NAFLD, incluidos los casos con fibrosis significativa que tienen m\u00e1s probabilidades de experimentar una enfermedad hep\u00e1tica avanzada y la mortalidad relacionada.<\/p>\n\n\n\n

M\u00e9todos<\/h3>\n\n\n\n

Se utiliz\u00f3 un modelo de progresi\u00f3n de la enfermedad para resumir y proyectar la progresi\u00f3n de la fibrosis entre las poblaciones de EHGNA de Hong Kong, Singapur, Corea del Sur y Taiw\u00e1n. Para cada \u00e1rea, los cambios en la prevalencia de obesidad en adultos se utilizaron para extrapolar las tendencias a largo plazo en la incidencia de NAFLD.<\/p>\n\n\n\n

Resultados<\/h3>\n\n\n\n

En las \u00e1reas estudiadas, se proyect\u00f3 que los casos prevalentes de NAFLD aumentar\u00edan 6%-20% durante 2019-2030, mientras que los casos prevalentes de NASH aumentar\u00edan 20%-35%. Se prev\u00e9 que los casos incidentes de carcinoma hepatocelular aumenten en 65%-85%, mientras que los casos incidentes de cirrosis descompensada aumentan en 65%-100% para 2030. Asimismo, se prev\u00e9 que la mortalidad relacionada con NAFLD aumente entre 65% y 100% de 2019 a 2030. Se espera la carga de enfermedad de NAFLD aumentar junto con las tendencias crecientes del s\u00edndrome metab\u00f3lico y la obesidad entre las poblaciones de la regi\u00f3n. Esto conduce a m\u00e1s casos de enfermedad hep\u00e1tica avanzada y mortalidad asociada.<\/p>\n\n\n\n

Conclusiones<\/h3>\n\n\n\n

La prevenci\u00f3n del crecimiento de poblaciones diab\u00e9ticas y obesas ser\u00e1 un factor clave para reducir los aumentos en curso en la carga de enfermedades relacionadas con la EHGNA en la regi\u00f3n de Asia y el Pac\u00edfico.<\/p>\n\n\n\n

Pa\u00edses:<\/strong> Hong Kong, Singapur, Corea del Sur, Taiw\u00e1n<\/p>\n\n\n\n

\n
Lea el informe completo<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Summary Background Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) account for an increasing proportion of liver disease in the Asia-Pacific region. Many areas in the region are experiencing epidemics of metabolic syndrome among rapidly ageing populations. Aims To estimate using modelling the growth in NAFLD populations, including cases with significant fibrosis that are […]<\/p>\n","protected":false},"author":24,"featured_media":3187,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[12,24],"publication-author":[683,684,681,535,685,688,690,687,686,691,682,689,694,494,664,692,693,506],"class_list":["post-3093","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-modelling","tag-nafld","publication-author-chan-hly","publication-author-chien-rn","publication-author-chuang-wl","publication-author-estes-c","publication-author-fung-j","publication-author-goh-gb","publication-author-hu-th","publication-author-huang-jf","publication-author-jang-bk","publication-author-jun-dw","publication-author-kao-jh","publication-author-lee-jw","publication-author-lin-hc","publication-author-razavi-h","publication-author-razavi-shearer-k","publication-author-seto-wk","publication-author-wong-gl","publication-author-wong-vw"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/3093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/comments?post=3093"}],"version-history":[{"count":5,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/3093\/revisions"}],"predecessor-version":[{"id":7481,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/3093\/revisions\/7481"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media\/3187"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media?parent=3093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/categories?post=3093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/tags?post=3093"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/publication-author?post=3093"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}